Mitsubishi Pharma to Use BioWisdom's Sofia KnowledgeScan Service | GenomeWeb
NEW YORK (GenomeWeb News) — Mitsubishi Pharma will use BioWisdom’s Sofia KnowledgeScan software services in its drug-discovery programs, BioWisdom said today.
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.